Nilotinib (Tasigna) Therapy Post Allogeneic Stem Cell Transplantation (AlloSCT) for Advanced (>CP1) Chronic Myeloid Leukemia (CML) and Ph+ Acute Lymphoblastic Leukemia (ALL)

✍ Scribed by A. Nagler; Y. Volchek; N. Varda-Bloom; R. Somech; R. Yerushalmi; A. Shimoni

• Book ID: 116283240
• Publisher: Elsevier Science
• Year: 2012
• Tongue: English
• Weight: 51 KB
• Volume: 18
• Category: Article
• ISSN: 1083-8791
• DOI: 10.1016/j.bbmt.2011.12.430